We are live on ! Find out more
KPP

Kings Path Partners Portfolio holdings

AUM $376M
1-Year Est. Return 19.8%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+19.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$376M
AUM Growth
+$85M
Cap. Flow
+$59.2M
Cap. Flow %
15.76%
Top 10 Hldgs %
54.62%
Holding
367
New
75
Increased
70
Reduced
42
Closed
14

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.2%
2 Healthcare 1.84%
3 Energy 1.84%
4 Financials 1.65%
5 Technology 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRMD icon
51
iRadimed
IRMD
$1.07B
$654K 0.17%
6,840
CVLG icon
52
Covenant Logistics
CVLG
$889M
$649K 0.17%
14,680
+4,039
+38% +$147K
PNTG icon
53
Pennant Group
PNTG
$1.33B
$648K 0.17%
17,550
MCB icon
54
Metropolitan Bank Holding Corp
MCB
$1.16B
$638K 0.17%
6,460
AAPL icon
55
Apple
AAPL
$4.67T
$614K 0.16%
2,121
+769
+57% +$220K
BFST icon
56
Business First Bancshares
BFST
$1.04B
$608K 0.16%
19,770
WULF icon
57
TeraWulf
WULF
$8.24B
$606K 0.16%
24,535
UFPT icon
58
UFP Technologies
UFPT
$2.24B
$586K 0.16%
2,210
AGX icon
59
Argan
AGX
$5.86B
$569K 0.15%
713
-109
-13% -$72.5K
TILT icon
60
Northern Trust Morningstar US Market Factor Tilt ETF
TILT
$2.25B
$560K 0.15%
2,030
-5
-0.2% -$1.33K
TFIN icon
61
Triumph Financial Inc
TFIN
$1.66B
$554K 0.15%
7,255
BNDW icon
62
Vanguard Total World Bond ETF
BNDW
$1.88B
$540K 0.14%
7,876
-5
-0.1% -$341
PAHC icon
63
Phibro Animal Health
PAHC
$1.55B
$539K 0.14%
17,155
GRBK icon
64
Green Brick Partners
GRBK
$3.06B
$536K 0.14%
6,701
ANIP icon
65
ANI Pharmaceuticals
ANIP
$1.64B
$513K 0.14%
6,200
IJH icon
66
iShares Core S&P Mid-Cap ETF
IJH
$126B
$503K 0.13%
6,524
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.08T
$496K 0.13%
991
+36
+4% +$17.3K
PLPC icon
68
Preformed Line Products
PLPC
$1.95B
$474K 0.13%
1,155
BLFS icon
69
BioLife Solutions
BLFS
$1.72B
$468K 0.12%
16,570
WLDN icon
70
Willdan Group
WLDN
$1.31B
$467K 0.12%
5,910
+3,050
+107% +$260K
SCHR
71
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$450K 0.12%
18,268
+513
+3% +$12.7K
LMAT icon
72
LeMaitre Vascular
LMAT
$1.84B
$449K 0.12%
4,675
BIL icon
73
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$432K 0.12%
4,718
-502
-10% -$45.9K
GRDN
74
Guardian Pharmacy Services
GRDN
$2.58B
$431K 0.11%
10,300
TSLA icon
75
Tesla
TSLA
$1.4T
$421K 0.11%
1,000

Similar funds

Kings Path Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Kings Path Partners held 367 positions worth $376M, up 29% from $291M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Kings Path Partners deployed $59.2M of net new capital in Q2 2026, opening 75 new positions and adding to 70 existing holdings. Its largest new stake was Tortoise MLP ETF: 147,412 shares worth $4.08M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, up from 89% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Schwab International Equity ETF, an estimated $686K trimmed.

  • Kings Path Partners's largest Q2 2026 buy was Tortoise MLP ETF: 147,412 shares worth $4.08M.
  • Kings Path Partners added most to Vanguard Morningstar Total Stock Market ETF in Q2 2026, an estimated $7.13M increase.
  • Kings Path Partners's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $686K.
  • Kings Path Partners fully exited i3 Verticals in Q2 2026, selling an estimated $453K.
  • Kings Path Partners's ten largest holdings make up 55% of its $376M portfolio in Q2 2026.
  • Kings Path Partners opened 75 new positions and closed 14 in Q2 2026.
  • Kings Path Partners's portfolio value rose 29% quarter-over-quarter to $376M.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.